High-dose ocular infection with a herpes simplex virus type 1 ICP34.5 deletion mutant produces no corneal disease or neurovirulence yet results in wild-type levels of spontaneous reactivation

Journal of Virology

Volumn 70, Issue 5, 1996, Pages 2883-2893

  Perng, Guey Chuen ^a   Ghiasi, Homayon ^a,b   Slanina, Susan M ^a   Nesburn, Anthony B ^a,b   Wechsler, Steven L ^a,b  

^a CEDARS SINAI MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; DELETION MUTANT; DOSE RESPONSE; FEMALE; HERPES SIMPLEX KERATITIS; HERPES SIMPLEX VIRUS 1; IN SITU HYBRIDIZATION; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; RABBIT; VIRUS INFECTIVITY; VIRUS LATENCY; VIRUS MUTANT; VIRUS REACTIVATION;

EID: 0029985561     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.70.5.2883-2893.1996     Document Type: Article

References (23)

1. - are attenuated for neurovirulence in mice and for replication in confluent primary mouse embryo cells. J. Virol. 68:48-55
2. Chou, J., E. R. Kern, R. J. Whitley, and B. Roizman. 1990. Mapping of herpes simplex virus-neurovirulence to gamma 134.5, a gene nonessential for growth in culture. Science 250:1262-1265.
3. Gordon, Y. J., T. Araullo-Cruz, E. Romanowski, and J. L. C. McKnight. 1992. A critical role for latency frequency (Lf) in the evaluation of HSV-1 experimental reactivation, abstr. 2207. ARVO Suppl. Invest. Ophthalmol. Visual Sci. 1992:1134.
4. Gordon, Y. J., E. Romanowski, T. Araullo-Cruz, and P. R. Kinchington. The percentage of trigeminal ganglia neurons expressing herpes simplex virus type 1 latency associated transcript correlates to reactivation in the New Zealand White rabbit model. Grahfes Arch. Ophthalmol., in press
5. Katz, J. P., E. T. Bodin, and D. M. Coen. 1990. Quantitative polymerase chain reaction analysis of herpes simplex virus DNA in ganglia of mice infected with replication-incompetent mutants. J. Virol. 64:4288-4295.
6. Lagunoff, M., and B. Roizman. 1994. Expression of a herpes simplex virus 1 open reading frame antisense to the γ1 34.5 gene and transcribed by an RNA 3′ terminal with the unspliced latency-associated transcript. J. Virol. 68:6021-6028.
7. + between immediate early gene 1 and the "a" sequence J. Gen. Virol. 72:631-639.
8. Nesburn, A. B. (ed.), 1983. Report of the corneal disease panel. Vision research, a national plan 1983-1987, vol. II, part III. The C. V. Mosby Co., St Louis.
9. Nesburn, A. B., R. L. Burke, S. M. Slanina, S. Bahri, H. Ghiasi, and S. L. Wechsler. 1994. A therapeutic vaccine against ocular herpes simplex virus type 1 (HSV-1) recurrences reduced rate of spontaneous ocular HSV-1 shedding in latently infected rabbits J. Virol. 68:5084-5092.
10. Nesburn, A. B., H. Ghiasi, and S. L. Wechsler. 1990. Ocular safety and efficacy of an HSV-1 gD vaccine during primary and latent infection. Invest. Ophthalmol. Visual Sci. 31:77-82.
11. Nesburn, A. B., C. Robinson, and R. Dickinson. 1974. Adenine arabinoside effect on experimental idoxuridine-resistant herpes simplex infection. Invest. Ophthalmol. 4:302-304.
12. Nesburn, A. B., and M. D. Trousdale. 1981 Treatment of acute and chronic ocular herpes infection with acyclovir, p. 309-314. In R. Sundmacher (ed.), Herpetische Augenerkrankungen. J. F. Bergmann Verlag, Munich.
13. 12a.Perng, G.-C., K. Chokephaibulkit, R. L. Thompson, N. M. Sawtell, S. M. Slanina, H. Ghiasi, A. B. Nesburn, and S. L. Wechsler. 1996. The region of the herpes simplex virus type 1 LAT gene that is colinear with the ICP34.5 gene is not involved in spontaneous reactivation. J. Virol 70:282-291.
14. Perng, G. C., E. C. Dunkel, P. A. Geary, S. M. Slanina, H. Ghiasi, R. Kaiwar, A. B. Nesburn, and S. L. Wechsler. 1994 The latency-associated transcript gene of herpes simplex virus type 1 (HSV-1) is required for efficient in vivo spontaneous reactivation of HSV-1 from latency. J. Virol. 68:8045-8055.
15. Perng, G. C., R. L. Thompson, N. M. Sawtell, W. E. Taylor, S. M. Slanina, H. Ghiasi. R. Kaiwar, A. B. Nesburn, and S. L. Wechsler. 1995. An avirulent ICP34.5 deletion mutant of herpes simplex virus type 1 is capable of in vivo spontaneous reactivation. J. Virol. 69:3033-3041.
16. Robertson, L. M., A. R. MacLean, and S. M. Brown. 1992. Peripheral replication and latency reactivation kinetics of the non-neurovirulent herpes simplex virus type 1 variant 1716. J. Gen. Virol. 73:967-970
17. Rock, D. L., A. B. Nesburn, H. Ghiasi, J. Ong, T. L. Lewis, J. R. Lokensgard, and S. L. Wechsler. 1987. Detection of latency-related viral RNAs in trigeminal ganglia of rabbits latently infected with herpes simplex virus type 1. J. Virol. 61:3820-3826.
18. Sacks, W. R., and P. A. Schaffer. 1987. Deletion mutants in the gene encoding the herpes simplex virus type 1 immediate-early protein ICP0 exhibit impaired growth in cell culture. J. Virol 61:829-539.
19. Thompson, R. L., E. K. Wagner, and J. G. Stevens. 1983. Physical location of a herpes simplex virus type 1 gene function(s) specifically associated with a 10 million fold increase in HSV neurovirulence. Virology 131:180-192.
20. Wechsler, S. L., A. B. Nesburn, R. J. Watson, S. Slanina, and H. Ghiasi. 1988. Fine mapping of the major latency-related RNA of herpes simplex virus type 1 in humans. J. Gen. Virol. 69:3101-3106.
21. Wechsler, S. L., A. B. Nesburn, R. J. Watson, S. M. Slanina, and H. Ghiasi. 1988. Fine mapping of the latency-related gene of herpes simplex virus type 1: alternative splicing produces distinct latency-related RNAs containing open reading frames. J Virol. 62:4051-4058.
22. Whitley, R. J., E. R. Kern, S. Chatterjee, J. Chou, and B. Roizman. 1993. Replication, establishment of latency, and induced reactivation of herpes simplex virus gamma 1 34.5 deletion mutants in rodent models. J. Clin. Invest. 91:2837-2843.
23. Yeh, L., and P. A. Schaffer. 1993. A novel class of transcripts expressed with late kinetics in the absence of ICP4 spans the junction between the long and short segments of the herpes simplex virus type 1 genome. J. Virol. 67:7373-7382.